Home » Health »
Latest News »
New York Times »
NYT
» Regeneron says its antibody treatment may not be as effective against Omicron, but testing is underway.
Regeneron says its antibody treatment may not be as effective against Omicron, but testing is underway.
By BY BENJAMIN MUELLER from NYT Health https://ift.tt/3EaJuoT
via IFTTT
0 Response to "Regeneron says its antibody treatment may not be as effective against Omicron, but testing is underway."
Post a Comment